Osteoporosis drug may benefit heart health

May 11th, 2018 | Posted by admin in Uncategorized

The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack, and stroke in a study of patients with hip fractures.
Source: Health Medicine Science Daily

You can follow any responses to this entry through the RSS 2.0 You can leave a response, or trackback.

Leave a Reply

Your email address will not be published. Required fields are marked *